MAPK Signaling
MAPK Signaling(MAPK信号通路)
MAPK Signaling 相关产品(575)
- GC10069NSC 23766 trihydrochlorideCAS: 1177865-17-6纯度: >99.50% / >99.00%
NSC 23766 trihydrochloride是一种选择性Rac1 GTPase抑制剂,通过特异性阻断Rac1的鸟嘌呤核苷酸交换因子Trio和Tiam1来抑制Rac1的激活,对Rac1的IC₅₀约为50μM。
- GC12151B-Raf inhibitorCAS: 1315330-11-0纯度: >98.50%
B-Raf inhibitor 是一种有效的双重 TGFβ-activated kinase 1 (TAK1) 和 mitogen-activated protein kinase kinase kinase 2 (MAP4K2) 抑制剂,IC50 分别为 41.1 nM 和 18.2 nM。
- GC12482BRAF inhibitorCAS: 918505-61-0纯度: >98.50%
BRAF 抑制剂是从专利 WO/2011103196 A1 化合物 P-0850 中提取的 B-Raf 抑制剂。
- GC12706cAMPS-Sp, triethylammonium saltCAS: 73208-40-9
cAMPS-Sp,三乙基铵盐,一种 cAMP 类似物,是一种有效的、竞争性 cAMP 诱导的 cAMP 依赖性 PKA I 和 II 的激活(Kis 分别为 12.5 μ;M 和 4.5 μ;M)拮抗剂。
- GC12824Dibutyryl-cAMP, sodium saltCAS: 16980-89-5纯度: >99.50% / >98.00% / >99.00%
Dibutyryl-cAMP, sodium salt,又称为Bucladesine,是一种细胞膜可透性环核苷酸类似物,能模拟内源性cAMP的作用,并作为磷酸二酯酶抑制剂。
- GC12970FurosemideCAS: 54-31-9纯度: >99.50% / >98.00%
A loop diuretic and an inhibitor of NKCC1 and NKCC2
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10030 | EHop-016 | 1380432-32-5 | >99.00% | |
EHop-016是一种高效的Rac GTP酶Rac1抑制剂,IC 50 值为1.1μM。 | ||||
| GC10033 | Cobimetinib | 934660-93-2 | >99.50% | |
Cobimetinib是一种强效、选择性的MEK1抑制剂,IC 50 值为0.9nM。 | ||||
| GC10069 | NSC 23766 trihydrochloride | 1177865-17-6 | >99.50% / >99.00% | |
NSC 23766 trihydrochloride是一种选择性Rac1 GTPase抑制剂,通过特异性阻断Rac1的鸟嘌呤核苷酸交换因子Trio和Tiam1来抑制Rac1的激活,对Rac1的IC₅₀约为50μM。 | ||||
| GC10110 | PD318088 | 391210-00-7 | >99.50% | |
An allosteric inhibitor of MEK1 | ||||
| GC10446 | CC-930 | 899805-25-5 | >99.50% | |
A potent JNK inhibitor | ||||
| GC10528 | Salirasib | 162520-00-5 | >98.00% | |
A Ras inhibitor with anti-cancer and anti-atherogenic activity | ||||
| GC10693 | c-JUN peptide | 610273-01-3 | - | |
JNK/c-Jun interaction inhibitor | ||||
| GC10941 | cAMPS-Rp, triethylammonium salt | 151837-09-1 | >99.00% | |
A non-hydrolyzable analog of cAMP | ||||
| GC11599 | B-Raf inhibitor 1 | 1093100-40-3 | >98.00% | |
An inhibitor of Raf kinases | ||||
| GC11649 | MLN 2480 | 1096708-71-2 | >98.50% | |
An oral pan-Raf kinase inhibitor | ||||
| GC11685 | GW5074 | 220904-83-6 | >99.00% | |
A potent inhibitor of Raf-1 | ||||
| GC11890 | SB590885 | 405554-55-4 | >98.00% | |
A potent inhibitor of B-Raf | ||||
| GC12151 | B-Raf inhibitor | 1315330-11-0 | >98.50% | |
B-Raf inhibitor 是一种有效的双重 TGFβ-activated kinase 1 (TAK1) 和 mitogen-activated protein kinase kinase kinase 2 (MAP4K2) 抑制剂,IC50 分别为 41.1 nM 和 18.2 nM。 | ||||
| GC12482 | BRAF inhibitor | 918505-61-0 | >98.50% | |
BRAF 抑制剂是从专利 WO/2011103196 A1 化合物 P-0850 中提取的 B-Raf 抑制剂。 | ||||
| GC12691 | XMD17-109 | 1435488-37-1 | >98.00% | |
A selective ERK5 inhibitor | ||||
| GC12706 | cAMPS-Sp, triethylammonium salt | 73208-40-9 | - | |
cAMPS-Sp,三乙基铵盐,一种 cAMP 类似物,是一种有效的、竞争性 cAMP 诱导的 cAMP 依赖性 PKA I 和 II 的激活(Kis 分别为 12.5 μ;M 和 4.5 μ;M)拮抗剂。 | ||||
| GC12819 | PD98059 | 167869-21-8 | >98.00% | |
D98059是一种有效的选择性MEK抑制剂,IC50为2 μM。 | ||||
| GC12824 | Dibutyryl-cAMP, sodium salt | 16980-89-5 | >99.50% / >98.00% / >99.00% | |
Dibutyryl-cAMP, sodium salt,又称为Bucladesine,是一种细胞膜可透性环核苷酸类似物,能模拟内源性cAMP的作用,并作为磷酸二酯酶抑制剂。 | ||||
| GC12843 | MEK162 (ARRY-162, ARRY-438162) | 606143-89-9 | >99.50% | |
A MEK1/2 inhibitor | ||||
| GC12882 | AS 602801 | 848344-36-5 | >99.50% | |
A selective, orally bioavailable JNK inhibitor | ||||
| GC12926 | VX-745 | 209410-46-8 | >99.00% / >98.00% | |
A p38α MAPK inhibitor | ||||
| GC12970 | Furosemide | 54-31-9 | >99.50% / >98.00% | |
A loop diuretic and an inhibitor of NKCC1 and NKCC2 | ||||
| GC13115 | VX-11e | 896720-20-0 | >99.00% | |
A selective ERK inhibitor | ||||
| GC13286 | ZM336372 | 208260-29-1 | - | |
An activator of the Raf-1 signalling pathway | ||||
